46
Participants
Start Date
June 30, 2008
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Posaconazole
200 mg three times daily by mouth up to 6 weeks (Days 1-42)
ABLC
7.5 mg/kg of ABLC intravenously infused over 4-6 hours once per week, for up to 6 weeks (from Day 1 through Day 42)
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Enzon Pharmaceuticals, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER